Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Brainstorm Cell Therapeutics

Brainstorm Cell Therapeutics reported $2.93M in Current Assets for its fiscal quarter ending in March of 2023.

Current Assets Change
Aceragen Inc IDRA:US USD 17.86M 12.21M
Adamis Pharmaceuticals ADMP:US USD 7.55M 1.73M
Biogen BIIB:US USD 9.76B 28.7M
Brainstorm Cell Therapeutics BCLI:US USD 2.93M 177K
Cytokinetics CYTK:US USD 680.63M 114.56M
Gilead Sciences GILD:US USD 14.37B 855M
Halozyme Therapeutics HALO:US USD 615.02M 123.99M